Allison Goodman

ORCID: 0000-0001-9833-5148
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Phagocytosis and Immune Regulation
  • Immune cells in cancer
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Immunotherapy and Biomarkers
  • T-cell and Retrovirus Studies
  • Biosimilars and Bioanalytical Methods
  • Nanofabrication and Lithography Techniques
  • Advanced Biosensing Techniques and Applications
  • Gender Diversity and Inequality
  • Cultural Industries and Urban Development
  • Technology Assessment and Management
  • Protein purification and stability
  • Neuroscience and Neural Engineering
  • Career Development and Diversity

AbCellera (Canada)
2023-2024

ArtCenter College of Design
2024

Bureau of Labor Statistics
2024

United States Department of Labor
2024

Tumor-associated macrophages (TAM) play an important role in maintaining the immunosuppressive state of tumor microenvironment (TME). High levels CD163+ TAMs specifically are associated with poor prognosis many solid types. Targeting may represent a key approach development next generation cancer immune therapeutics. Members leukocyte immunoglobulin-like receptor B (LILRB) family, including LILRB2 (ILT4), known to transmit inhibitory signals and other myeloid cells. Leveraging bulk single...

10.1158/1535-7163.mct-22-0351 article EN Molecular Cancer Therapeutics 2023-02-10

Abstract Accessing peptides from intracellular tumor antigens displayed on MHC class I (pMHC) can expand the T-cell engager (TCE) target pool for solid applications. A challenge limiting TCE development pMHC targets is identification of rare, high-affinity, and high-specificity pMHC-binders. In this work, we describe TCEs in a 1 × format with potent tumor-cell killing activity high specificity MAGE-A4, antigen expressed multiple cancer types. We identified functional MAGE-A4 x CD3 affinity...

10.1158/1538-7445.am2024-2373 article EN Cancer Research 2024-03-22

<h3>Background</h3> CD3 T-cell engagers (TCEs) represent a promising approach in cancer immunotherapy, yet challenges efficacy and safety have hindered clinical development. To address these barriers, we developed TCE platform comprised of novel CD3-binding antibodies, bispecific engineering technology, high-throughput process for identifying pairs CD3- tumor-binding antibodies with desired properties. By assessing hundreds formats, identified rare CD3-binders that can be used to create TCEs...

10.1136/jitc-2024-sitc2024.1291 article EN cc-by-nc Regular and Young Investigator Award Abstracts 2024-11-01

Abstract The research detailed in this paper focuses on the career experiences of women who obtained degrees between 1979 and 1983. Exploring women's achievements, challenges, reflections their work STEM professions using Social Cognitive Career Theory, recommendations are provided for educators to prepare both men long term professional careers. Especially women, being equipped with research-based, practical skills strategies has potential increase retention these professions.

10.18260/1-2--39139 article EN 2024-02-08

Abstract In this study, we used a functional approach to generate CD3 T-cell engager (TCE) molecules targeting prostate-specific membrane antigen (PSMA). We present data on the robust in vitro characterization of activity and selection for further assessment. TCE function is dictated by interplay between multiple factors that form immune synapse, including binding kinetics, geometry, epitopes CD3- tumor-binding arms. To diversify synapse parameters, engineer hundreds bispecific from highly...

10.1158/1538-7445.am2024-6359 article EN Cancer Research 2024-03-22

Abstract In this study, we present data from four T-cell engager (TCE) programs in which leveraged our highly diverse CD3-binding antibodies to generate functional bispecifics for each tumor target. By aggregating tumor-cell killing and cytokine across targets with different properties target expression levels, have gained novel insights into target-specific considerations the development of CD3 TCEs. TCEs recapitulate a synapse between T cells cells. cell function downstream is determined...

10.1158/1538-7445.am2024-1868 article EN Cancer Research 2024-03-22

10.1535/itj.1102.02 article EN Intel Technology Journal 2007-05-16

&lt;div&gt;Abstract&lt;p&gt;Tumor-associated macrophages (TAM) play an important role in maintaining the immunosuppressive state of tumor microenvironment (TME). High levels CD163&lt;sup&gt;+&lt;/sup&gt; TAMs specifically are associated with poor prognosis many solid types. Targeting may represent a key approach development next generation cancer immune therapeutics. Members leukocyte immunoglobulin-like receptor B (LILRB) family, including LILRB2 (ILT4), known to transmit inhibitory signals...

10.1158/1535-7163.c.6534805 preprint EN 2023-04-03
Coming Soon ...